Research Article
Thiopurines in the Management of Crohn’s Disease: Safety and Efficacy Profile in Patients with Normal TPMT Activity—A Retrospective Study
Table 2
Side effect profile of thiopurine therapy over study period.
| | Full dose () | Low dose () | value |
| Patients with complications | 42 (49%) | 24 (49%) | 1.000 | GI intolerance | 16 (19%) | 7 (14%) | 0.636 | Hepatitis | 5 (6%) | 1 (2%) | 0.415 | Pancreatitis | 2 (2%) | 5 (10%) | 0.0992 | Myelosuppression | 8 (9%) | 5 (10%) | 1.000 | Others | 12 (14%) | 6 (12%) | 1.000 | Discontinued treatment | 24 (28%) | 19 (39%) | 0.250 |
|
|